The second dose of the BNT162b2 mRNA vaccine does not boost SARS-CoV-2 neutralizing antibody response in previously infected subjects.
| Publicado en: | Infection Vol. 50; no. 2; pp. 541 - 544 |
|---|---|
| Autores principales: | , , , , , , , , |
| Formato: | letter tables/charts Journal Article |
| Publicado: |
Springer Nature
Apr2022
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=155912969&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 155912969 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 03008126 NXO jtl: Infection issn: 03008126 maglogo: N pubinfo: dt: Apr2022 vid: 50 iid: 2 pid: 237 pub: Springer Nature place: New York, New York artinfo: ui: 155912969 151715744 155912969 155912969 10.1007/s15010-021-01680-z 155912969 ppf: 541 ppct: 3 formats: fmt: – @attributes: type: T – @attributes: type: P tig: atl: The second dose of the BNT162b2 mRNA vaccine does not boost SARS-CoV-2 neutralizing antibody response in previously infected subjects. aug: au: Vicenti, Ilaria Gatti, Francesca Scaggiante, Renzo Boccuto, Adele Zago, Daniela Basso, Monica Dragoni, Filippo Parisi, Saverio Giuseppe Zazzi, Maurizio affil: Department of Medical Biotechnologies, University of Siena, Siena, Italy sug: subj: COVID-19 COVID-19 Vaccines Administration and Dosage Neutralizing Antibodies pubtype: Academic Journal doctype: letter tables/charts Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|